MARKET

SLP

SLP

Simulations Plus Inc
NASDAQ
12.65
+0.19
+1.52%
After Hours: 12.78 +0.13 +1.03% 19:39 04/07 EDT
OPEN
12.41
PREV CLOSE
12.46
HIGH
12.71
LOW
12.08
VOLUME
301.53K
TURNOVER
--
52 WEEK HIGH
36.45
52 WEEK LOW
11.09
MARKET CAP
254.85M
P/E (TTM)
-3.9584
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Simulations Plus (SLP) and Mediwound (MDWD)
TipRanks · 1d ago
Options Volatility and Implied Earnings Moves This Week, April 06 – April 10, 2026
TipRanks · 1d ago
Weekly Report: what happened at SLP last week (0330-0403)?
Weekly Report · 1d ago
Quant snapshot: Delta Air Lines leads top-rated names as Byrna Technologies, Simulations Plus lag
Seeking Alpha · 2d ago
Analysts Offer Insights on Healthcare Companies: Simulations Plus (SLP) and Sanara MedTech (SMTI)
TipRanks · 5d ago
Weekly Report: what happened at SLP last week (0323-0327)?
Weekly Report · 03/30 09:48
Press Release: Simulations Plus Announces Second Quarter Fiscal Year 2026 Earnings and Conference Call Date
Dow Jones · 03/26 20:35
Simulations Plus schedules FY2026 Q2 earnings release; conference call set for 5:00 p.m. ET
Reuters · 03/26 20:11
More
About SLP
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.

Webull offers Simulations Plus Inc stock information, including NASDAQ: SLP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SLP stock methods without spending real money on the virtual paper trading platform.